Back to top

Pharma Mar Wins New Global Approvals for Zepzelca Lung Cancer Regimen

Pharma Mar SA ( ($ES:PHM) ) has provided an update. Pharma Mar has secured approvals in Canada, Qatar and South Korea for Zepzelca (lurbinectedin) ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

PulteGroup, Inc. (PHM)

Pharma Mar (PHMMF)